| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/08/2004 | EP1454987A1 Polypeptides translocated into cells by the VirB/VirD4 type IV secretion system and uses thereof |
| 09/08/2004 | EP1454986A1 Vanadium haloperoxidases from the brown alga Laminaria digitata and uses thereof |
| 09/08/2004 | EP1454985A2 Modulators of receptors of the tnf/ngf receptor family |
| 09/08/2004 | EP1454984A1 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases |
| 09/08/2004 | EP1454983A1 Process for recovery of nucleic acids |
| 09/08/2004 | EP1454980A2 Female sex hormone degrading bacteria and use thereof |
| 09/08/2004 | EP1454917A2 Diabody-type bispecific antibody |
| 09/08/2004 | EP1454916A1 Modified cDNA factor VIII and its derivatives |
| 09/08/2004 | EP1454915A1 Polynucleotides, polypeptides and method for screening for useful dog candidates |
| 09/08/2004 | EP1454914A1 Tumor antigen |
| 09/08/2004 | EP1454628A2 Medical use of p38/JTV-1 |
| 09/08/2004 | EP1454525A1 NONHUMAN MODEL ANIMAL OF Th2-MEDIATED HYPERIMMUNE RESPONSE |
| 09/08/2004 | EP1454524A1 Hcv gene transgenic animal |
| 09/08/2004 | EP1454177A1 Multi-substrate biochip unit |
| 09/08/2004 | EP1454142A2 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 09/08/2004 | EP1454139A2 Immobilizing biological molecules |
| 09/08/2004 | EP1453982A2 Modulating urea degradation in wine yeast |
| 09/08/2004 | EP1453981A1 Methylotrophic bacterium for the production of recombinant proteins and other products |
| 09/08/2004 | EP1453980A2 Maize ccoaomt2 gene polymorphism, and uses thereof to enhance plant digestibility |
| 09/08/2004 | EP1453979A2 Multiplex pcr |
| 09/08/2004 | EP1453978A2 Analysis and detection of multiple target sequences using circular probes |
| 09/08/2004 | EP1453977A2 Molecular characteristics of non-small cell lung cancer |
| 09/08/2004 | EP1453976A2 Method for analyzing translation-controlled gene expression |
| 09/08/2004 | EP1453975A1 Method for detecting hybridization events in nucleic acids |
| 09/08/2004 | EP1453974A2 Profiling of the immune gene repertoire |
| 09/08/2004 | EP1453973A1 Methods for determining transcriptional activity |
| 09/08/2004 | EP1453968A2 Bgl4 beta-glucosidase and nucleic acids encoding the same |
| 09/08/2004 | EP1453967A2 Bgl5 beta-glucosidase and nucleic acids encoding the same |
| 09/08/2004 | EP1453966A1 Method for producing a recombinant polypeptide |
| 09/08/2004 | EP1453965A2 Dna vaccine |
| 09/08/2004 | EP1453964A2 Genes coding for stress resistance and tolerance proteins |
| 09/08/2004 | EP1453963A2 A structure for presenting desired peptide sequences |
| 09/08/2004 | EP1453962A2 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 09/08/2004 | EP1453961A2 Stabilisation of double-stranded nucleic acids using proteins |
| 09/08/2004 | EP1453960A1 Dna construct for assessing thymic function activity and therapeutical uses thereof |
| 09/08/2004 | EP1453958A1 Regulation of human serine/threonine protein kinase |
| 09/08/2004 | EP1453952A2 Compositions and methods for normalizing assays |
| 09/08/2004 | EP1453950A2 Nucleic acid molecules from rice encoding proteins for abiotic stress tolerance, enhanced yield, disease resistance and altered nutritional quality and uses thereof |
| 09/08/2004 | EP1453948A2 Cell culture process |
| 09/08/2004 | EP1453862A2 Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases |
| 09/08/2004 | EP1453857A1 Chromatographic purification of recombinant human erythropoietin |
| 09/08/2004 | EP1453856A1 Beta-amyloid binding factors and inhibitors thereof |
| 09/08/2004 | EP1453855A1 Antimicrobial bolisin peptides |
| 09/08/2004 | EP1453854A2 Human cdnas and proteins and uses thereof |
| 09/08/2004 | EP1453853A2 Mixture of peptides originating from a nef protein and applications thereof |
| 09/08/2004 | EP1453850A2 Egviii endoglucanase and nucleic acids encoding the same |
| 09/08/2004 | EP1453849A2 Antisense modulation of purinoreceptor p2x3 |
| 09/08/2004 | EP1453845A2 Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same |
| 09/08/2004 | EP1453608A2 Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 09/08/2004 | EP1453602A2 Compositions and methods for separating heterocyclic aromatic amine bases, nucleosides, nucleotides, and nucleotide sequences |
| 09/08/2004 | EP1453583A2 Extraction and winterization of lipids from oilseed and microbial sources |
| 09/08/2004 | EP1453547A2 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor |
| 09/08/2004 | EP1453543A2 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 09/08/2004 | EP1453538A2 Method of purifying hepatitis a virus particles and vaccine preparation |
| 09/08/2004 | EP1453537A1 Composition for viral preservation |
| 09/08/2004 | EP1453536A1 Composition for the preservation of viruses |
| 09/08/2004 | EP1453534A1 A process for the preparation of a non-toxic anthrax vaccine |
| 09/08/2004 | EP1453533A1 Migration of hematopoietic stem cells and progenitor cells to th e liver |
| 09/08/2004 | EP1453532A2 Taojiks as modifiers of the beta-catenin pathway and methods of use |
| 09/08/2004 | EP1453531A2 Use of hmgb proteins and nucleic acids that code therefor |
| 09/08/2004 | EP1453530A2 Method of proliferation in neurogenic regions |
| 09/08/2004 | EP1453496A2 Composition and method for modulating bar/fxr receptor activity |
| 09/08/2004 | EP1453484A2 Methods and materials for detecting genetic material |
| 09/08/2004 | EP1453471A2 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 09/08/2004 | EP1453383A2 A novel saitohin gene and uses of same |
| 09/08/2004 | EP1453382A2 Methods and compositions for correction of cardiac conduction disturbances |
| 09/08/2004 | EP1409510A4 Biological pacemaker |
| 09/08/2004 | EP1399459A4 Reagent for the isolation of rna |
| 09/08/2004 | EP1294867B1 Human site-1 protease promoter |
| 09/08/2004 | EP1272637A4 A METHOD FOR SCREENING FOR AUTOIMMUNE DISEASE BY IDENTIFYING POLYMORPHISMS IN IL-12 p40 |
| 09/08/2004 | EP1224327A4 Compounds displayed on replicable genetic packages and methods of using same |
| 09/08/2004 | EP1223798B1 Method for producing a bank or collection of mutants and applications thereof |
| 09/08/2004 | EP1174501B1 Gene expression base sequences for therapeutic use and drugs for gene therapy |
| 09/08/2004 | EP1131087B1 Methods of alleviating cancer symptoms |
| 09/08/2004 | EP1129216B1 Methods, software and apparati for identifying genomic regions harboring a gene associated with a detectable trait |
| 09/08/2004 | EP1126870B1 Use of vegf-c or vegf-d gene or protein to prevent restenosis |
| 09/08/2004 | EP1084261B1 Recombinant venezuelan equine encephalitis virus vaccine |
| 09/08/2004 | EP1077993A4 Generation of combinatorial libraries of compounds corresponding to virtual libraries of compounds |
| 09/08/2004 | EP1017802B1 A potential effector for the grb7 family of signalling proteins |
| 09/08/2004 | EP0960127A4 Isolated dimeric fibroblast activation protein alpha, and uses thereof |
| 09/08/2004 | EP0927188B1 Novel nucleoside analogs with polycyclic aromatic groups attached, methods of synthesis and uses therefor |
| 09/08/2004 | EP0922099B1 Fas ligand-like protein, its production and use |
| 09/08/2004 | EP0892852B1 Encapsulated cells expressing cytochrome p450 for prodrug activation |
| 09/08/2004 | EP0873405B1 Expression augmenting sequence elements (ease) for eukaryotic expression systems |
| 09/08/2004 | EP0870042B1 Improved methods for transforming phaffia strains, transformed phaffia strains so obtained and recombinant dna in said methods |
| 09/08/2004 | EP0792284B1 Novel polypeptides |
| 09/08/2004 | EP0750663B1 Apparatus and method for efficient incorporation of molecules into cells |
| 09/08/2004 | EP0739355B1 Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof |
| 09/08/2004 | CN1527944A In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells |
| 09/08/2004 | CN1527941A Methods using 06-alkylguanine-DNA alkyltransferase |
| 09/08/2004 | CN1527885A Detection system |
| 09/08/2004 | CN1527883A Leporipox-based vector vaccines |
| 09/08/2004 | CN1527882A Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides |
| 09/08/2004 | CN1527881A Novel enzymes and genes coding for the same derived from methylophilus methy lot rophus |
| 09/08/2004 | CN1527880A Enhanced 2-keto-L-gulonic acid production |
| 09/08/2004 | CN1527879A Nucleic acid and protein sequences of bovine epidermal growth factor |
| 09/08/2004 | CN1527839A Modified human brain-derived neutrophic factor (BDNF) with reduced immunogenicity |
| 09/08/2004 | CN1527719A Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiongenesis |
| 09/08/2004 | CN1527716A Anti-virus agent |
| 09/08/2004 | CN1527663A Novel pesticidal toxins |